Mylan Institutional, Inc. Recall: Levothyroxine Sodium Tablets, USP, 125 mcg (0.125 mg), 1
Mylan Institutional, Inc. Recall: Levothyroxine Sodium Tablets, USP, 125 mcg (0.125 mg), 1 is one of 9,000 recalls in the RecallGuard dataset. Key details — Recalling firm: Mylan Institutional, Inc.; Product: Levothyroxine Sodium Tablets, USP, 125 mcg (0.125 mg), 100 Tablets per carton (10 unit dose blister cards of 10
| Recalling firm | Mylan Institutional, Inc. |
|---|---|
| Product | Levothyroxine Sodium Tablets, USP, 125 mcg (0.125 mg), 100 Tablets per carton (10 unit dose blister cards of 10 tablets each), Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA. NDC: 51079-443-20 |
| Reason for recall | Subpotent and Superpotent Drug |
| Classification | Class II (moderate — may cause temporary or reversible health consequences) |
| Status | Ongoing |
| Distribution | Nationwide in the USA. |
| Recall initiated | 20241119 |
| Recall number | D-0133-2025 |
| Category | drug |
| State | IL |
| Country | United States |
$29/mo
Try RecallGuard →